NJ State Employees Deferred Compensation Plan’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$1.72M | – | 511 |
|
|
2021
Q3 | $1.72M | Hold |
10,000
| – | – | 0.23% | 106 |
|
|
2021
Q2 | $1.25M | Hold |
10,000
| – | – | 0.17% | 141 |
|
|
2021
Q1 | $1.36M | Hold |
10,000
| – | – | 0.19% | 125 |
|
|
2020
Q4 | $1.28M | Hold |
10,000
| – | – | 0.2% | 120 |
|
|
2020
Q3 | $1.13M | Hold |
10,000
| – | – | 0.2% | 110 |
|
|
2020
Q2 | $952K | Hold |
10,000
| – | – | 0.18% | 117 |
|
|
2020
Q1 | $899K | Hold |
10,000
| – | – | 0.21% | 111 |
|
|
2019
Q4 | $530K | Hold |
10,000
| – | – | 0.09% | 254 |
|
|
2019
Q3 | $395K | Buy |
10,000
+4,000
| +67% | +$174K | 0.07% | 308 |
|
|
2019
Q2 | $247K | Hold |
6,000
| – | – | 0.04% | 482 |
|
|
2019
Q1 | $280K | Sell |
6,000
-1,000
| -14% | -$43.9K | 0.05% | 449 |
|
|
2018
Q4 | $305K | Hold |
7,000
| – | – | 0.06% | 371 |
|
|
2018
Q3 | $401K | Hold |
7,000
| – | – | 0.07% | 384 |
|
|
2018
Q2 | $340K | Hold |
7,000
| – | – | 0.06% | 410 |
|
|
2018
Q1 | $274K | Hold |
7,000
| – | – | 0.05% | 418 |
|
|
2017
Q4 | $297K | Hold |
7,000
| – | – | 0.05% | 412 |
|
|
2017
Q3 | $261K | Hold |
7,000
| – | – | 0.05% | 412 |
|
|
2017
Q2 | $213K | Buy |
+7,000
| New | +$203K | 0.04% | 384 |
|
|
2016
Q4 | – | Sell |
-7,000
| Closed | -$254K | – | 369 |
|
|
2016
Q3 | $254K | Hold |
7,000
| – | – | 0.05% | 322 |
|
|
2016
Q2 | $238K | Hold |
7,000
| – | – | 0.05% | 331 |
|
|
2016
Q1 | $223K | Hold |
7,000
| – | – | 0.05% | 338 |
|
|
2015
Q4 | $342K | Buy |
+7,000
| New | +$252K | 0.07% | 312 |
|
|
2015
Q3 | – | Sell |
-7,000
| Closed | -$221K | – | 387 |
|
|
2015
Q2 | $221K | Hold |
7,000
| – | – | 0.04% | 349 |
|
|
2015
Q1 | $267K | Hold |
7,000
| – | – | 0.05% | 335 |
|
|
2014
Q4 | $273K | Hold |
7,000
| – | – | 0.05% | 339 |
|
|
2014
Q3 | $212K | Hold |
7,000
| – | – | 0.04% | 360 |
|
|
2014
Q2 | $238K | Hold |
7,000
| – | – | 0.05% | 359 |
|
|
2014
Q1 | $241K | Hold |
7,000
| – | – | 0.05% | 357 |
|
|
2013
Q4 | $277K | Buy |
+7,000
| New | +$169K | 0.06% | 351 |
|
NJ State Employees Deferred Compensation Plan's XLRN Position: Q4 2021 in Review
NJ State Employees Deferred Compensation Plan sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 10,000 shares — an estimated $1.72M sold.
NJ State Employees Deferred Compensation Plan first reported a position in XLRN in Q4 2013 and held it in 29 quarters. The position peaked at $1.72M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- NJ State Employees Deferred Compensation Plan reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- NJ State Employees Deferred Compensation Plan sold 10,000 Acceleron Pharma shares in Q4 2021, an estimated $1.72M.
- NJ State Employees Deferred Compensation Plan first reported a position in Acceleron Pharma in Q4 2013 and held it in 29 quarters.
- NJ State Employees Deferred Compensation Plan's Acceleron Pharma position peaked at $1.72M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2021, filed 31 Jan 2022.